[地区外科中心中倍他司汀在耳蜗和前庭疾病中的疗效]
[Betaserk efficiency in cochlear and vestibular disorders in the regional surdocenter].
作者信息
Pekaskiĭ S I
出版信息
Vestn Otorinolaringol. 2001(3):61.
PMID:11510053
Abstract
The results are available of the outpatient treatment of 10 patients with cochlear and vestibular disorders with the drug betaserk. The previous treatment was ineffective. Surdological indications for betaserk are described.
摘要
现将使用倍他司汀药物对10例患有耳蜗和前庭疾病的患者进行门诊治疗的结果公布如下。先前的治疗无效。文中描述了使用倍他司汀的耳科学指征。
相似文献
1
[Betaserk efficiency in cochlear and vestibular disorders in the regional surdocenter].
Vestn Otorinolaringol. 2001(3):61.
2
[The use of betaserk in patients with cochlear-vestibular disorders].
Vestn Otorinolaringol. 1998(5):49-50.
3
[Betaserk in therapy of cochleovestibular disordes].
Vestn Otorinolaringol. 2006(4):59-60.
4
[The role of betaserk in combined treatment of neurosensory hypoacusis and vestibulopathy in childhood].
Vestn Otorinolaringol. 2004(2):9-12.
5
[Vestibo in the treatment of cochleovestibular disorders].
Vestn Otorinolaringol. 2008(6):52-4.
6
[Vestibular disorders in patients with otosclerosis: prevalence, diagnostic and therapeutic options].
Vestn Otorinolaringol. 2009(2):20-2.
7
[Betahistine in the treatment of vestibular and coordination disturbances in multiple sclerosis].
Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(2 Pt 2):77-81.
8
[Betaserk in the treatment of aftereffects of craniocerebral injury and vascular events].
Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(7):55-7.
9
[Rehabilitation of patients with peripheral vestibular disorders].
Vestn Otorinolaringol. 2004(2):59-61.
10
[Efficacy of betaserk in experimental motor disease].
Vestn Otorinolaringol. 2005(6):49-52.
Zotero 插件